Relationship of CYP2D6 status and toremifene metabolism

被引:1
|
作者
Kim, J. [1 ]
Dalton, J. T. [1 ]
Veverka, K. A. [1 ]
机构
[1] GTx Inc, Memphis, TN USA
关键词
D O I
10.1200/jco.2011.29.15_suppl.e13068
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13068
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Importance of CYP2D6 metabolism in the in vitro antiestrogenic activity of toremifene and tamoxifen
    Coss, C.
    Barrett, C.
    Kim, J.
    Li, C.
    Dalton, J. T.
    Veverka, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [3] CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status
    Gaedigk, A
    Bradford, LD
    Alander, SW
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 563 - 569
  • [4] Metabolism of antipsychotics and CYP2D6 genotype
    Schmider, J
    Walter, S
    Sachse, C
    Bauer, S
    Müller-Oerlinghausen, B
    Roots, I
    Brockmöller, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R459 - R459
  • [5] CYP2D6 status in tobacco smokers
    Piguet, V
    Bouchardy, C
    Benhamou, S
    Dayer, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PIV25 - PIV25
  • [6] Nicotine metabolism and CYP2D6 phenotype in smokers
    Caporaso, NE
    Lerman, C
    Audrain, J
    Boyd, NR
    Main, D
    Issaq, HJ
    Utermahlan, B
    Falk, RT
    Shields, P
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (03) : 261 - 263
  • [7] CYP2D6 phenotype and the metabolism of nicotine and cotinine
    Benowitz, NL
    Jacob, P
    PerezStable, E
    PHARMACOGENETICS, 1996, 6 (03): : 239 - 242
  • [8] CYP2D6 is primarily responsible for the metabolism of clomiphene
    Ghobadi, Cyrus
    Gregory, Anne
    Crewe, H. Kim
    Rostami-Hodjegan, Amin
    Lennard, Martin S.
    DRUG METABOLISM AND PHARMACOKINETICS, 2008, 23 (02) : 101 - 105
  • [9] Enantioselective metabolism of primaquine by human CYP2D6
    Pius S Fasinu
    Babu L Tekwani
    NP Dhammika Nanayakkara
    Bharathi Avula
    HMT Bandara Herath
    Yan-Hong Wang
    Vijender R Adelli
    Mahmoud A Elsohly
    Shabana I Khan
    Ikhlas A Khan
    Brandon S Pybus
    Sean R Marcsisin
    Gregory A Reichard
    James D McChesney
    Larry A Walker
    Malaria Journal, 13
  • [10] Enantioselective metabolism of primaquine by human CYP2D6
    Fasinu, Pius S.
    Tekwani, Babu L.
    Nanayakkara, N. P. Dhammika
    Avula, Bharathi
    Herath, H. M. T. Bandara
    Wang, Yan-Hong
    Adelli, Vijender R.
    Elsohly, Mahmoud A.
    Khan, Shabana I.
    Khan, Ikhlas A.
    Pybus, Brandon S.
    Marcsisin, Sean R.
    Reichard, Gregory A.
    McChesney, James D.
    Walker, Larry A.
    MALARIA JOURNAL, 2014, 13